Clinical Trial Update: National Survey on Infiltrative Breast Cancer

View source ↗

Summary

AstraZeneca-sponsored clinical trial investigating invasive breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Infiltrative Breast Cancer | Status: COMPLETED